Synthesis and Evaluation of Hydrophilic Linkers for Antibody-Maytansinoid Conjugates

被引:147
|
作者
Zhao, Robert Y. [1 ]
Wilhelm, Sharon D. [1 ]
Audette, Charlene [1 ]
Jones, Gregory [1 ]
Leece, Barbara A. [1 ]
Lazar, Alexandru C. [1 ]
Goldmacher, Victor S. [1 ]
Singh, Rajeeva [1 ]
Kovtun, Yelena [1 ]
Widdison, Wayne C. [1 ]
Lambert, John M. [1 ]
Chari, Ravi V. J. [1 ]
机构
[1] ImmunoGen Inc, Waltham, MA 02451 USA
关键词
CALICHEAMICIN CONJUGATE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; CANCER; CELLS; DOXORUBICIN; ACID; TRANSPORTERS; CHEMOTHERAPY; SPECIFICITY;
D O I
10.1021/jm2002958
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and biological evaluation of hydrophilic heterobifunctional cross-linkers for conjugation of antibodies with highly cytotoxic agents are described. These linkers contain either a negatively charged sulfonate group or a hydrophilic, noncharged PEG group in addition to an amine-reactive N-hydroxysuccinimide (NHS) ester and sulfhydryl reactive termini. These hydrophilic linkers enable conjugation of hydrophobic organic molecule drugs, such as a maytansinoid, at a higher drug/antibody ratio (DAR) than hydrophobic SPDB and SMCC linkers used earlier without triggering aggregation or loss of affinity of the resulting conjugate. Antibody maytansinoid conjugates (AMCs) bearing these sulfonate- or PEG-containing hydrophilic linkers were, depending on the nature of the targeted cells, equally to more cytotoxic to antigen-positive cells and equally to less cytotoxic to antigen-negative cells than conjugates made with SPDB or SMCC linkers and thus typically displayed a wider selectivity window, particularly against multidrug resistant (MDR) cancer cell lines in vitro and tumor xenograft models in vivo.
引用
收藏
页码:3606 / 3623
页数:18
相关论文
共 50 条
  • [1] Enhancing the antitumor activity of antibody-maytansinoid conjugates with hydrophilic linkers
    Wilhelm, Sharon
    Zhao, Robert
    Singh, Rajeeva
    Widdison, Wayne
    Clancy, Lauren
    Maloney, Erin
    Kellogg, Brenda
    Audette, Charlene
    Kovtun, Yelena
    Mayo, Michele
    Chari, Ravi V. J.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 237
  • [2] ADME of Antibody-Maytansinoid Conjugates
    Erickson, Hans K.
    Lambert, John M.
    AAPS JOURNAL, 2012, 14 (04): : 799 - 805
  • [3] DISPOSITION OF ANTIBODY-MAYTANSINOID CONJUGATES
    Sun, Xiuxia
    DRUG METABOLISM REVIEWS, 2012, 44 : 14 - 14
  • [4] Antibody-maytansinoid conjugates for the treatment of myeloma
    Lutz, Robert J.
    Whiteman, Kathleen R.
    MABS, 2009, 1 (06) : 548 - 551
  • [5] DESIGNING ANTIBODY-MAYTANSINOID CONJUGATES FOR ANTICANCER THERAPY
    Kovtun, Yelena
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3361 - 3361
  • [6] Metabolites of Antibody-Maytansinoid Conjugates: Characteristics and in Vitro Potencies
    Widdison, Wayne
    Wilhelm, Sharon
    Veale, Karen
    Costoplus, Juliet
    Jones, Gregory
    Audette, Charlene
    Leece, Barbara
    Bartle, Laura
    Kovtun, Yelena
    Chari, Ravi
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 1762 - 1773
  • [7] Antibody-maytansinoid conjugates with hydrophilic linkers: cytotoxic therapeutics with enhanced potency against cancer cells with low antigen number and multidrug resistance
    Kellogg, Brenda
    Maloney, Erin
    Okamoto, Michael
    Fishkin, Nathan
    Erickson, Hans
    Sun, Xiuxia
    Wilhelm, Sharon
    Zhao, Robert
    Pinkas, Jan
    Mayo, Michele
    Kovtun, Yelena
    Chari, Ravi
    Singh, Rajeeva
    CANCER RESEARCH, 2009, 69
  • [8] ANTIBODY-MAYTANSINOID CONJUGATES: A NEW STRATEGY FOR THE TREATMENT OF CANCER
    Lambert, J. M.
    DRUGS OF THE FUTURE, 2010, 35 (06) : 471 - 480
  • [9] Antibody-Maytansinoid Conjugates Designed to Bypass Multidrug Resistance
    Kovtun, Yelena V.
    Audette, Charlene A.
    Mayo, Michele F.
    Jones, Gregory E.
    Doherty, Heather
    Maloney, Erin K.
    Erickson, Hans K.
    Sun, Xiuxia
    Wilhelm, Sharon
    Ab, Olga
    Lai, Katharine C.
    Widdison, Wayne C.
    Kellogg, Brenda
    Johnson, Holly
    Pinkas, Jan
    Lutz, Robert J.
    Singh, Rajeeva
    Goldmacher, Victor S.
    Chari, Ravi V. J.
    CANCER RESEARCH, 2010, 70 (06) : 2528 - 2537
  • [10] Effects of drug load on therapeutic index for antibody-maytansinoid conjugates
    Sun, Xiuxia
    Ponte, Jose F.
    Yoder, Nicholas C.
    Coccia, Jennifer
    Lanieri, Leanne
    Laleau, Rassol
    Qiu, Qifeng
    Wu, Rui
    Hong, Erica
    Bogalhas, Megan
    Wang, Lintao
    Maloney, Erin K.
    Ab, Olga
    Erickson, Hans K.
    Keating, Thomas A.
    Chari, Ravi
    Lambert, John M.
    CANCER RESEARCH, 2015, 75